Also trades as: PHRX.CN (CNQ) · $vol 0M
LMLLF OTC
Pharmadrug Inc.
1W: -20.0%
1M: -32.7%
3M: -26.9%
YTD: -58.4%
1Y: -57.5%
3Y: -94.8%
5Y: -99.4%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$757K
-12.6% ▼
Capital Expenditures
$12K
+0.0% ▲
5Y CAGR: -8.9%
Free Cash Flow
-$769K
-14.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$449K
-181.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$6M | -$3M | -$13M | -$873K |
| Depreciation & Amort. | $1M | $1M | $21K | $26K | $50K |
| Stock-Based Comp. | $775K | $600K | $345K | $2M | $47K |
| Change in Working Capital | -$252K | -$132K | $687K | -$58K | -$303K |
| Other Non-Cash Items | $5M | $831K | -$56K | $12M | $322K |
| Operating Cash Flow | -$1M | -$4M | -$2M | -$672K | -$757K |
| — Investing Activities — | |||||
| Capital Expenditures | -$18K | -$43K | $0 | $0 | -$12K |
| Acquisitions (Net) | $2M | $309K | -$12K | $742K | $0 |
| Investment Purchases | -$492K | $43K | $0 | $0 | $0 |
| Investment Sales | $2M | $1M | $94K | $0 | $0 |
| Other Investing | $0 | -$43K | -$4K | $253K | $0 |
| Investing Cash Flow | $4M | $1M | $78K | $995K | -$12K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$302K | $0 | $602K | $4K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $235K | $777K | -$39K | $222K | -$4K |
| Financing Cash Flow | $132K | $777K | $843K | $226K | $322K |
| Net Change in Cash | $2M | -$1M | -$949K | $552K | -$449K |
| Cash End of Period | $2M | $958K | $9K | $560K | $111K |
| Free Cash Flow | -$1M | -$4M | -$2M | -$672K | -$769K |